[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 48, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1097468, "exercisedValue": 0, "unexercisedValue": 469825}, {"maxAge": 1, "name": "Mr. Alexander Mark Schobel", "age": 65, "title": "Chief Innovation & Technology Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 2595296, "exercisedValue": 0, "unexercisedValue": 324350}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 68, "title": "Chief Legal Officer, Chief Compliance Officer & Secretary", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 737771, "exercisedValue": 0, "unexercisedValue": 255600}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "age": 54, "title": "Senior Vice President of Sales & Marketing", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 58, "title": "Senior Vice President of Information Technology & Human Resources", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl N. Kraus M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Melina T. Cioffi", "age": 41, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.31, "open": 3.31, "dayLow": 3.28, "dayHigh": 3.505, "regularMarketPreviousClose": 3.31, "regularMarketOpen": 3.31, "regularMarketDayLow": 3.28, "regularMarketDayHigh": 3.505, "payoutRatio": 0.0, "beta": 1.933, "forwardPE": -5.6749997, "volume": 606150, "regularMarketVolume": 606150, "averageVolume": 1542609, "averageVolume10days": 1543740, "averageDailyVolume10Day": 1543740, "bid": 2.49, "ask": 4.36, "bidSize": 1, "askSize": 2, "marketCap": 338211520, "fiftyTwoWeekLow": 2.12, "fiftyTwoWeekHigh": 5.8, "priceToSalesTrailing12Months": 6.236843, "fiftyDayAverage": 2.9262, "twoHundredDayAverage": 3.61695, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 299253440, "profitMargins": -1.0001999, "floatShares": 93524197, "sharesOutstanding": 99327904, "sharesShort": 12003700, "sharesShortPriorMonth": 9840455, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.120799996, "heldPercentInsiders": 0.05619, "heldPercentInstitutions": 0.48758, "shortRatio": 5.96, "shortPercentOfFloat": 0.1434, "impliedSharesOutstanding": 99327904, "bookValue": -0.613, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -54239000, "trailingEps": -0.58, "forwardEps": -0.6, "enterpriseToRevenue": 5.518, "enterpriseToEbitda": -7.388, "52WeekChange": 0.36776865, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 3.405, "targetHighPrice": 15.0, "targetLowPrice": 4.75, "targetMeanPrice": 8.41667, "targetMedianPrice": 8.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 68657000, "totalCashPerShare": 0.691, "ebitda": -40506000, "totalDebt": 39135000, "quickRatio": 4.323, "currentRatio": 4.873, "totalRevenue": 54228000, "revenuePerShare": 0.588, "returnOnAssets": -0.22209999, "grossProfits": 37093000, "freeCashflow": -20214250, "operatingCashflow": -48775000, "revenueGrowth": -0.277, "grossMargins": 0.68402, "ebitdaMargins": -0.74696, "operatingMargins": -2.22076, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "regularMarketChange": 0.09500003, "regularMarketDayRange": "3.28 - 3.505", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1542609, "fiftyTwoWeekLowChange": 1.2850001, "fiftyTwoWeekLowChangePercent": 0.60613215, "fiftyTwoWeekRange": "2.12 - 5.8", "fiftyTwoWeekHighChange": -2.3950002, "fiftyTwoWeekHighChangePercent": -0.41293105, "fiftyTwoWeekChangePercent": 36.776863, "earningsTimestamp": 1747080061, "earningsTimestampStart": 1754305140, "earningsTimestampEnd": 1754654400, "earningsCallTimestampStart": 1747137600, "earningsCallTimestampEnd": 1747137600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.58, "epsForward": -0.6, "epsCurrentYear": -0.68667, "priceEpsCurrentYear": -4.9587135, "fiftyDayAverageChange": 0.47880006, "fiftyDayAverageChangePercent": 0.16362521, "twoHundredDayAverageChange": -0.21195006, "regularMarketChangePercent": 2.8700914, "regularMarketPrice": 3.405, "marketState": "REGULAR", "longName": "Aquestive Therapeutics, Inc.", "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketTime": 1751393742, "shortName": "Aquestive Therapeutics, Inc.", "twoHundredDayAverageChangePercent": -0.058599114, "priceToBook": -5.5546494, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]